In the Press

Featured
Recent

BioMotiv Opens Philadelphia Office

BioMotiv has established a Philadelphia office as it continues to grow. The office is located in The Innovation Hub, a collaborative life sciences space managed by Militia Hill Ventures, next to 30th Street...

BioMotiv Featured in Drug Discovery World

“Emerging drug discovery alliance models” discusses the current environment for early-stage drug discovery and development, highlights challenges to success, and suggests the need for allied partnerships in the drug development sphere using BioMotiv as one such model....

BioMotiv at AUTM 2018 Annual Meeting

Our colleague, Kaushik Ghosal, will be joining the Association of University Technology Managers (AUTM) 2018 Annual Meeting as a panelist at the "Creative Models to De-Risk Early Stage BioMedical Technology Development" session on February 21. He will present...

Allinaire Awarded Grant for Novel Pulmonary Treatment

CLEVELAND and INDIANAPOLIS, February 12, 2018 - Allinaire Therapeutics has been awarded a Phase I Small Business Technology Transfer grant from the National Heart, Lung and Blood Institute. Allinaire's aim is to support the advancement of new drug therapies for...

2018 Harrington Scholar-Innovators Selected

CLEVELAND, OHIO, January 18 - Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, part of The Harrington Project for Discovery & Development, has announced its 2018 Harrington Scholar-Innovator Award recipients.  The 10 physician-scientists...

Social Finance Forum: Navigating Impact in Health

TORONTO, November 2017 – Baiju Shah joined international leaders in the social finance and impact investing space for the 10th Annual Social Finance Forum. He represented BioMotiv on the Navigating Impact in Health panel to discuss innovative approaches to the drug...

Collaboration in Action: Drug Discovery Alliance Models

BOSTON, November 2017 --  The Association of Strategic Alliance Professionals hosted the 2017 BioPharma Conference. BioMotiv’s Senior Vice President, Technical Operations, Chuck McOsker, PhD, represented BioMotiv on the panel discussing Strategic Perspectives on...

Koutif Therapeutics Launched to Treat Inflammatory Diseases

CLEVELAND AND PITTSBURGH, September 21, 2017 -  BioMotiv, a drug development accelerator, and the University of Pittsburgh announced the launch of Koutif Therapeutics, which is developing an inhibitor of an E3 ligase (Fbxo3) to treat inflammatory conditions such as...

Allinaire Awarded $1.9M in Grant Funding

CLEVELAND and INDIANAPOLIS, September 19, 2017 - Allinaire Therapeutics has been awarded a $1,670,000 Phase II SBIR grant from the National Heart, Lung, and Blood Institute (NHLBI) and a $213,000 Discovery Award from the Department of Defense (DOD). The funding will...